Development of a novel microRNA mimic for cancer treatment [ 2016 - 2017 ]

Research Grant

Researchers: Prof Peter Leedman (Principal investigator) ,  Dr Christopher Wraight

Brief description Liver cancer is a major health burden globally, with a very poor prognosis. New treatments are urgently needed. We have developed proof-of-concept data showing that a tiny RNA, called a microRNA, is a powerful inhibitor of liver cancer growth. We will use this grant application to further develop the microRNA with novel chemistry so that it can be readily translated into early phase clinical trials in the near future.

Funding Amount $AUD 545,555.57

Funding Scheme Development Grants

Notes Development Grant